Epsilogen Announces the Appointment of Cristina Oliva, MD, PhD as Chief Medical Officer
Board-certified oncologist who brings over 20 years of senior clinical development experience across large pharmaceutical, biotechnology and Clinical Research Organizations
Epsilogen, the world’s leading pan-isotype antibody therapeutic company for the treatment of cancer, today announces the appointment of Cristina Oliva, MD, PhD, as Chief Medical Officer. Dr. Oliva is a Board-certified oncologist and brings global experience across all stages of oncology drug development.
Dr. Oliva joins Epsilogen from BerGenBio, where she served as Chief Medical Officer from 2022. Prior to this role, Dr. Oliva was Vice President, Oncology and Head of Oncology Centre of Excellence at IQVIA, where she led a cross-functional team of oncology subject matter experts and established and led the IQVIA Oncology Global Scientific Advisory Board. Dr. Oliva has also held senior positions, leading oncology development programs, at Nordic Nanovector, Takeda Pharmaceuticals, GSK and Eli Lilly.
Tim Wilson, CEO of Epsilogen, said: “I am delighted to welcome Cristina to Epsilogen. I believe her extensive experience in oncology drug development will be invaluable as we continue to advance MOv18 IgE through Phase Ib studies and progress other assets from our unique IgE, IgA and IgG-based therapeutics platforms towards the clinic.”
Cristina Oliva, Chief Medical Officer of Epsilogen, commented: “I am thrilled to be joining Epsilogen at such an exciting time in the Company’s growth and look forward to advancing Epsilogen’s assets addressing high unmet medical needs”
About Epsilogen Ltd
Epsilogen is the world’s leading pan-isotype antibody therapeutic company for the treatment of cancer. It has unique and proprietary expertise in the discovery and development of IgE, IgA and IgG-based therapeutics with each isotype possessing differentiated immune effector function. IgE has significant activity against various tumour types by activating myeloid cells and T cells thereby warming up the tumour micro-environment (TME). IgA’s anti-cancer potential is mediated by the activation of neutrophils, highly abundant effector cells which drive innate and adaptive immunity. The distinct activity profiles of each isotype allow Epsilogen to select the most appropriate isotype for a given cancer. The company has also combined different isotypes into a single antibody molecule with enhanced functionality.
Epsilogen’s lead product candidate, MOv18 IgE, is the first therapeutic IgE antibody to enter the clinic and encouraging data from a completed Phase I trial found it to be safe and well tolerated with early signs of clinical activity. Epsilogen has initiated a Phase Ib trial in platinum-resistant ovarian cancer patients. Find out more at Epsilogen.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251006855233/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Global Sports Fans Demand Always-On Engagement From Their Favorite Teams7.10.2025 11:24:00 CEST | Press release
New Infobip study reveals supporters feel ‘disconnected’ and ‘priced out’ Research commissioned by global cloud communications platform Infobip reveals a growing demand among sports fans for always-on, personalized engagement with their favorite teams. The global study shows that two-thirds (66%) of fans feel disconnected due to poor club communication, rising to 81% among those under 35. The research of 1,500 American football, baseball, soccer, and cricket fans across the US, Europe, and India, uncovers widespread frustration with generic, one-way communication and a strong appetite for deeper relationships with clubs beyond game days. More than 70% of fans want ongoing communication during the off-season, including behind-the-scenes content and personal stories from players. Meanwhile, 82% currently use social media to follow their teams, though many expressed interest in richer, exclusive content through direct messaging and mobile apps. Many described current engagement as transac
Vektor Medical Secures CE Mark for vMap, Bringing the Benefits of Non-Invasive Arrhythmia Mapping to Europe7.10.2025 11:00:00 CEST | Press release
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, announced it has received CE Mark for the vMap® System, a non-invasive tool developed with AI that transforms standard 12-lead ECG data into 3D arrhythmia source maps in under a minute. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251007948309/en/ vMap is a non-invasive tool developed with AI that transforms standard 12-lead ECG data into 3D arrhythmia source maps in under a minute. vMap was invented to help physicians improve ablation outcomes for patients suffering from arrhythmias, such as atrial fibrillation and ventricular tachycardia. Use of vMap has also been associated with reductions in total procedure time. Previously available only in the United States, vMap has been successfully used in more than 2,000 procedures at more than 30 hospitals. Securing CE Mark creates the opportunity for hospitals and electrophysiologists (EPs) acros
Score the Top Fall Deals on Smart Home Essentials: EZVIZ Unveils Unbeatable Offers on Proven-In-Use Cameras and Fan-picked Entryway Upgrades for Hands-free, Worry-free Living7.10.2025 10:30:00 CEST | Press release
This fall, EZVIZ, the globally trusted name in smart home security, is marking the season with a special opportunity to upgrade your home protection. As the seasons change and families spend more time indoors, now is the perfect moment to invest in smart security that’s advanced, reliable, and effortless, helping you feel safe and connected all year round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251007988718/en/ This harvest season, EZVIZ offers unbeatable discounts to help people prepare for upgraded home living. For a limited time, the EZVIZ Fall Deals on Amazon UK bring exclusive savings on best-selling video doorbells, smart cameras, and all-in-one security kits. Whether you’re securing a city apartment or a spacious family home, these seasonal offers make it easier than ever to take meaningful steps toward peace of mind. Here are some of the top highlights: EP3X Pro Dual Lens Battery Video Doorbell with Chime– no
Bitdefender and OVHcloud Partner to Deliver Sovereign Cybersecurity to European Businesses7.10.2025 10:00:00 CEST | Press release
Partnership Advances In-Country Data Residency, Control, and Processing Aligned with French and European Union Regulatory Frameworks Bitdefender, a European-based company and a global cybersecurity leader, today announced a strategic partnership with OVHcloud, Europe’s leading cloud provider, to host its advanced cybersecurity platform on OVHcloud services in France. The partnership delivers sovereign cybersecurity ensuring customer and configuration data, security events, telemetry is never accessible, transferred, or processed outside the European Union (EU). The integration enables organizations to incorporate advanced cybersecurity capabilities to protect their operations and comply with rigorous French and EU regulations, while maintaining full control over data access and use. At the core of the initiative is Bitdefender GravityZone, a comprehensive unified security, risk analytics, and compliance platform, hosted on the OVHcloud SecNumCloud service. GravityZone provides advanced
Quectel Launches LR700A Smart Connected GNSS Receiver, an All-in-One Base Station Solution for Standalone Use or RTK Network Integration7.10.2025 09:00:00 CEST | Press release
Quectel Wireless Solutions, an end-to-end global IoT solutions provider, has introduced the Quectel LR700A smart connected GNSS receiver, an all-in-one high performance quad band base station solution, capable of connecting to the cloud to deliver GNSS correction data, usable either standalone or within an RTK station network. Available for use globally, the modular design integrates the GNSS receiver with cellular, Wi-Fi, and antenna systems, while providing extension slots for Zigbee short-range communication. Cellular connectivity makes the system highly versatile, enabling deployment anywhere without requiring existing infrastructure, ideal for establishing RTK correction services in remote locations. The integrated short-range communication capabilities make it ideal for pairing directly with nearby rovers, creating a complete RTK solution for localized high-precision applications. This quad-band GNSS receiver enables simultaneous reception of signals from GPS, Galileo, BDS, GLONA
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom